In another study, an in vitro and in vivo evaluation of the possibility and effectiveness of combining a C021 oncolytic virus, which targets ROR1-positive glioblastoma cells and activates IL-21 secretion in them, with anti-ROR1-CAR-NK cells was carried out [189]. The gene discussed is ROR1; the disease is glioblastoma.